SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001144204-18-050585
Filing Date
2018-09-25
Accepted
2018-09-25 06:06:39
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B3 tv503395_424b3.htm 424B3 5927
2 GRAPHIC image_001.jpg GRAPHIC 3750
  Complete submission text file 0001144204-18-050585.txt   12246
Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 6502444990
TITAN PHARMACEUTICALS INC (Filer) CIK: 0000910267 (see all company filings)

IRS No.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-226841 | Film No.: 181084607
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1